InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Schneider Eugene, Vice-Président Exécutif. Director active across 1 company, notably Ionis Pharmaceuticals INC. Aggregated, 4 filings have been recorded. Activity tracked since 15 October 2021. The latest transaction was disclosed on 18 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations4 total
10,400 shares0Common StockSEC:0000874015-22-000051:0
10,400 shares0Common StockSEC:0000874015-22-000051
417 shares0Common StockSEC:0000874015-21-000164:0
417 shares0Common StockSEC:0000874015-21-000164
4 of 4 declarations
About Schneider Eugene
Eugene Schneider is the Executive Vice President and Chief Clinical Development Officer at Ionis Pharmaceuticals Inc. He oversees clinical development programs and plays a key role in the company's research strategy.
